%0 Journal Article
%T Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive ALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization
%A Alexa B. Schrock
%A Atul Kulkarni
%A Doron Lipson
%A Eric Sanford
%A Garrett M. Frampton
%A Heather Wakelee
%A Heber MacMahon
%A James H. Suh
%A Jan Nowak
%A Jeffrey S. Ross
%A Jie He
%A Julia A. Elvin
%A Julian R. Molina
%A Juliann Chmielecki
%A Julie R. Brahmer
%A Justin Allen
%A Kashif Firozvi
%A Kyle Gowen
%A Marc Ladanyi
%A Marjorie Zauderer
%A Maureen Zakowski
%A Neil Fischbach
%A Nir Peled
%A Phil J. Stephens
%A Ravi Salgia
%A Roman Yelensky
%A Sai-Hong Ignatius Ou
%A Samuel J. Klempner
%A Shridar Ganesan
%A Siraj M. Ali
%A Smitha Menon
%A Thomas Hensing
%A Vincent A. Miller
%A Zachary Chalmers
%J Archive of "The Oncologist".
%D 2016
%R 10.1634/theoncologist.2015-0497
%K ALK
%K Crizotinib
%K Fluorescence in situ hybridization
%K Genomic profiling
%K Fusion
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912370/